Cite
HARVARD Citation
Holst, J. et al. (2020). High intratumoural galectin‐1 expression predicts adverse outcome in ALK− ALCL and CD30+ PTCL‐NOS. Hematological oncology. 38 (1), pp. 59-66. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Holst, J. et al. (2020). High intratumoural galectin‐1 expression predicts adverse outcome in ALK− ALCL and CD30+ PTCL‐NOS. Hematological oncology. 38 (1), pp. 59-66. [Online].